Vystar is strategically focusing on R3ALM Financial Ecosystem, and its RXAIR assets include FDA Class II devices.
2 reports, 1 independent
Updated Thu 00:00
No new developments lately
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vystar is strategically focusing on R3ALM Financial Ecosystem, and its RXAIR assets include FDA Class II devices.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Vystar acquires 50% stake in R3ALM and partners with Coin Age for tokenization.1 source
Vystar's strategic focus on R3ALM and its FDA Class II device assets.1 source